“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
Keywords
COVID-19
SARS-CoV-2
Vitamin D
Vitamin D3 or cholecalciferol
Calcifediol or 25-hydroxyvitamin D3
1α, 25(OH)2D or 1α, 25-dihydroxyvitamin D or calcitriol
Acute respiratory distress syndrome (ARDS)
Cytokine/Chemokine storm
Renin-angiotensin system
Hypercoagulability
Hydroxychloroquine
Chloroquine
Covidiol
Neutrophil activity
Vitamin D endocrine system
Cuboidal alveolar coating cells type II
Cathelicidin peptide
Defensins
TLR co-receptor CD14
Vitamin D receptor
Cited by (0)
© 2021 Published by Elsevier Ltd.